Document is current
Any future updates will be listed below
-
Authors
Hanifeh, Mohsen https://orcid.org/0000-0001-6534-3766
Sankari, Satu
Rajamäki, Minna M.
Syrjä, Pernilla
Kilpinen, Susanne
Suchodolski, Jan S.
Heilmann, Romy M.
Guadiano, Phillip
Lidbury, Jonathan
Steiner, Jörg M.
Spillmann, Thomas
-
Funding
Funding for this research was provided by:
Eläinlääketieteen Tutkimuksen Tukisäätiö (2013, 2014, 2015)
Doctoral Program in Clinical Veterinary Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland (2013, 2014)
- License Information
-
More Information
Article History
Received: 17 September 2017
Accepted: 22 March 2018
First Online: 4 April 2018
Ethics approval and consent to participate
: The clinical trial involving dogs with chronic enteropathies were also ethically approved by the same authority under the license numbers ESAVI/6973/04.10.03/2011 and ESAVI/10384/04.10.07/2014. Informed owner consent was obtained at the time the dogs were enrolled for gastroduodenoscopy, colonoscopy, or both. The samples from healthy Beagles were collected during post-mortem examinations after finalizing unrelated studies. These studies were approved by the Finnish National Animal Experiment Board (study license No. ESLH-2007-09833/Ym-23, ESAVI 2010-04178/Ym-23, and ESAVI/7290/04.10.03/2012).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
